DEHYDRATED ALCOHOL- alcohol injection, solution САЩ - английски - NLM (National Library of Medicine)

dehydrated alcohol- alcohol injection, solution

seton pharmaceuticals, llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - dehydrated alcohol injection, usp is indicated for therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated. relief of trigeminal neuralgia usually is only temporary. other conditions for which injection of alcohol has been reported include glossopharyngeal neuralgia,angina pectoris and severe claudication due to peripheral vascular insufficiency. alcohol concentrations of 40 to 50% (prepared by appropriate dilution of dehydrated alcohol) have been used for epidural or individual motor nerve injections to control certain manifestations of cerebral palsy and spastic paraplegia. similar concentrations also have been injected for celiac plexus block to relieve pain of inoperable upper abdominal cancer, and have been injected intra-and subcutaneously for relief of intractable pruritus ani. subarachnoid injection of dehydrated alcohol is

DEHYDRATED- alcohol solution САЩ - английски - NLM (National Library of Medicine)

dehydrated- alcohol solution

fisiopharma srl - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - dehydrated alcohol injection is indicated for therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (ticdouloureux), in patients for whom neurosurgical procedures are contraindicated. relief of trigeminal neuralgia usually is only temporary. other conditions for which injection of alcohol has been reported include glossopharyngeal neuralgia, angina pectoris and severe claudication due to peripheral vascular insufficiency. alcohol concentrations of 40 to 50% (prepared by appropriate dilution of dehydrated alcohol) have been used for epidural or individual motor nerve injections to control certain manifestations of cerebral palsy and spastic paraplegia. similar concentrations also have been injected for celiac plexus block to relieve pain of inoperable upper abdominal cancer, and have been injected intra-and subcutaneously for relief of intractable pruritus ani. subarachnoid injection of dehydrated alcohol is contr

Clindamycin + Benzoyl Peroxide 10 mg/g + 50 mg/g gel Ирландия - английски - HPRA (Health Products Regulatory Authority)

clindamycin + benzoyl peroxide 10 mg/g + 50 mg/g gel

european regulatory affairs t/a ivowen - clindamycin phosphate; benzoyl peroxide, hydrous - gel - 10 + 50 milligram(s)/gram - clindamycin, combinations

Clindamycin + Benzoyl Peroxide 10 mg/g + 50 mg/g gel Ирландия - английски - HPRA (Health Products Regulatory Authority)

clindamycin + benzoyl peroxide 10 mg/g + 50 mg/g gel

morningside healthcare (malta) limited - clindamycin phosphate; benzoyl peroxide, hydrous - gel - clindamycin, combinations

BOSENTAN CIPLA bosentan 125 mg (as monohydrate) tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

bosentan cipla bosentan 125 mg (as monohydrate) tablet blister pack

cipla australia pty ltd - bosentan monohydrate, quantity: 129.08 mg (equivalent: bosentan, qty 125 mg) - tablet, film coated - excipient ingredients: maize starch; sodium starch glycollate type b; povidone; pregelatinised maize starch; glycerol dibehenate; magnesium stearate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; purified water; ethylcellulose; cetyl alcohol; hydrogen peroxide; sodium lauryl sulfate; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - bosentan is indicated for the treatment of: - idiopathic pulmonary arterial hypertension - familial pulmonary arterial hypertension - pulmonary arterial hypertension associated with scleroderma or - pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger's physiology in patients with who functional class ii, iii or iv symptoms.

BOSENTAN CIPLA bosentan 125 mg (as monohydrate) tablet bottle Австралия - английски - Department of Health (Therapeutic Goods Administration)

bosentan cipla bosentan 125 mg (as monohydrate) tablet bottle

cipla australia pty ltd - bosentan monohydrate, quantity: 129.08 mg (equivalent: bosentan, qty 125 mg) - tablet, film coated - excipient ingredients: maize starch; sodium starch glycollate type b; povidone; pregelatinised maize starch; glycerol dibehenate; magnesium stearate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; purified water; ethylcellulose; cetyl alcohol; hydrogen peroxide; sodium lauryl sulfate; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - bosentan is indicated for the treatment of: - idiopathic pulmonary arterial hypertension - familial pulmonary arterial hypertension - pulmonary arterial hypertension associated with scleroderma or - pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger's physiology in patients with who functional class ii, iii or iv symptoms.

BOSENTAN CIPLA bosentan 62.5 mg (as monohydrate) tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

bosentan cipla bosentan 62.5 mg (as monohydrate) tablet blister pack

cipla australia pty ltd - bosentan monohydrate, quantity: 64.5 mg (equivalent: bosentan, qty 62.5 mg) - tablet, film coated - excipient ingredients: maize starch; sodium starch glycollate type b; povidone; pregelatinised maize starch; glycerol dibehenate; magnesium stearate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; purified water; ethylcellulose; cetyl alcohol; hydrogen peroxide; sodium lauryl sulfate; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - bosentan is indicated for the treatment of: - idiopathic pulmonary arterial hypertension - familial pulmonary arterial hypertension - pulmonary arterial hypertension associated with scleroderma or - pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger's physiology in patients with who functional class ii, iii or iv symptoms.

BOSENTAN CIPLA bosentan 62.5 mg  (as monohydrate) tablet bottle Австралия - английски - Department of Health (Therapeutic Goods Administration)

bosentan cipla bosentan 62.5 mg (as monohydrate) tablet bottle

cipla australia pty ltd - bosentan monohydrate, quantity: 64.5 mg (equivalent: bosentan, qty 62.5 mg) - tablet, film coated - excipient ingredients: maize starch; sodium starch glycollate type b; povidone; pregelatinised maize starch; glycerol dibehenate; magnesium stearate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; purified water; ethylcellulose; cetyl alcohol; hydrogen peroxide; sodium lauryl sulfate; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - bosentan is indicated for the treatment of: - idiopathic pulmonary arterial hypertension - familial pulmonary arterial hypertension - pulmonary arterial hypertension associated with scleroderma or - pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger's physiology in patients with who functional class ii, iii or iv symptoms.

PERUBATAN HOMEOPATHY RADZIAH DIAMILIGON TABLET 200MG Малайзия - английски - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

perubatan homeopathy radziah diamiligon tablet 200mg

perubatan homeopathy raziah - syzygium jambolanum 30c; momordica balasmina 30c; cantharis vesicatoria 30c; abroma augusta 30c -